![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/135 | |
A61K 9/00 | |||
A61K 9/10 | |||
A61K 9/16 | |||
A61K 9/28 | |||
A61K 9/48 |
(11) | Number of the document | 1715856 |
(13) | Kind of document | T |
(96) | European patent application number | 04815693.9 |
Date of filing the European patent application | 2004-12-23 | |
(97) | Date of publication of the European application | 2006-11-02 |
(45) | Date of publication and mention of the grant of the patent | 2012-07-11 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2004/043678 |
Date | 2004-12-23 |
(87) | Number | WO 2005/065673 |
Date | 2005-07-21 |
(30) | Number | Date | Country code |
533517 P | 2003-12-31 | US |
(72) |
BOEHM, Garth, US
DUNDON, Josephine, US
|
(73) |
Actavis Group PTC ehf.,
Reykjavikurvegi 76-78, 220 Hafnarfjordur,
IS
|
(54) | ATOMOXETINE FORMULATIONS |
ATOMOXETINE FORMULATIONS |